Please login to the form below

Not currently logged in
Email:
Password:

Medicines for Europe

This page shows the latest Medicines for Europe news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

medicines recommended for use in Europe on Friday. . ... Mayzent (siponimoid), developed by Swiss pharma Novartis, has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)

Latest news

  • Who's calling the shots in European healthcare? Who's calling the shots in European healthcare?

    EPHA says one of its core goals is to use ‘evidence-based advocacy’ to secure ‘better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and ... Natsis believes this is a pointer to the future

  • European elections: Eurosceptics and Greens rise, but big parties hold on European elections: Eurosceptics and Greens rise, but big parties hold on

    Moves to set out a strong coalition against pharma and its high prices for specialist medicines is also growing in Europe and beyond, with the issue gaining much attention at the ... Nevertheless, the new Commission is likely to continue its

  • As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority

    The ambition of rekindling its leadership in research-based innovation is an important issue for Europe, which is in danger of falling behind the US and China in terms of generating ... The European industry organisation has launched its own manifesto

  • Industry aghast as EU Parliament backs biosimilar rule change Industry aghast as EU Parliament backs biosimilar rule change

    Medicines for Europe – which represents European generics and biosimilar companies – has a different take of course, and says the move will prevent the “forced delocalisation of pharmaceutical manufacturing outside of Europe ... The future of

  • Europe’s medicines tracking system goes live Europe’s medicines tracking system goes live

    The organisation says that the EMVO system could well serve as a blueprint for securing the supply of medicines beyond Europe. ... The verification of the Unique Identifier and authentication happens in the National Medicines Verification System (NMVS).

More from news
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest Intelligence

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    Medicines for Europe vows to get  governments talking to realise potential. The future of generics and biosimilars is something to shout about but the sector fears the mute button has been ... Medicines for Europe is also trying to soften the

  • Interview: Cesar Rodriguez, Janssen Interview: Cesar Rodriguez, Janssen

    We cannot forget the fact that the UK has already among the lowest prices for medicines in Europe, and this is something that everybody should know. ... But this is not happening in all cases. “We still have one of the lowest rates of uptake for new

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Pfizer's Andrew Thomas takes up UK comms agency role

    Prior to joining the Creston Health Group agency he served at Pfizer as strategic communications lead for primary care medicines across Europe and Canada. ... During this time, he handled a portfolio that included many of the company's highest profile

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics